1.Morphological analysis of autophagy.
Acta Pharmaceutica Sinica 2016;51(1):39-44
Autophagy is an important homeostatic cellular recycling mechanism responsible for degrading injured or dysfunctional subcellular organelles and proteins in all living cells. The process of autophagy can be divided into three relatively independent steps: the initiation of phagophore, the formation of autophagosome and the maturation/degradation stage. Different morphological characteristics and molecular marker changes can be observed at these stages. Morphological approaches are useful to produce novel knowledge that would not be achieved through other experimental methods. Here we summarize the morphological methods in monitoring autophagy, the principles in data interpretation and the cautions that should be considered in the study of autophagy.
Autophagy
;
Homeostasis
;
Humans
;
Organelles
;
Phagosomes
2.New methods to detect autophagic flux.
Acta Pharmaceutica Sinica 2016;51(1):45-51
Autophagy is a crucial biological process of eukaryotes, which is involved in cell growth, survival and energy metabolism, while the premise of the autophagy function is activated autophagic flux. It has been confirmed that impaired autophagic flux promotes pathogenesis of many chronic inflammatory diseases, especially cancer, neurodegenerative disease and tissue fibrosis, therefore the analysis of autophagic flux state is important for revealing autophagy function and the mechanism of autophagy related diseases. Given that autophagy is a dynamic process with multiple steps, it is very hard to observe the real state of autophagic flux. Summarized here is the novel concept and current approach to detect autophagic flux. This knowledge is crucial for the researching of the biological function of autophagy, and may provide some strategies for developing autophagy-related drug.
Autophagy
;
Fibrosis
;
Humans
;
Inflammation
;
pathology
;
Neoplasms
;
pathology
;
Neurodegenerative Diseases
;
pathology
3.Progress of autophagy screening systems.
Jing XIE ; Xiao-wei ZHANG ; Fang HUA ; Zhuo-wei HU
Acta Pharmaceutica Sinica 2016;51(1):52-58
Autophagy is an active research area in the biomedical field as its role has been identified in many physiological and pathological processes. Accordingly, there is a growing demand to identify, quantify and manipulate the process accurately. Meanwhile, there is great interest in identifying compounds that modulate autophagy because they may have applications in the treatment of a variety of autophagy-related diseases. In this review, we summarize the current status of autophagy screening systems to facilitate identification of autophagy modulators.
Autophagy
;
Humans
4.Autophagy in ageing and ageing-related diseases.
Fang HUA ; Jiao-Jiao YU ; Ke LI ; Zhuo-Wei HU
Acta Pharmaceutica Sinica 2014;49(6):764-773
Autophagy is an important homeostatic cellular recycling mechanism responsible for degrading injured or dysfunctional cellular organelles and proteins in all living cells. Aging is a universal phenomenon characterized by progressive deterioration of cells and organs due to accumulation of macromolecular and organelle damage. Growing evidences indicate that the rate of autophagosome formation and maturation and the efficiency of autophagosome/lysosome fusion decline with age. Dysfunctional autophagy has also been observed in age-related diseases. Autophagy disruption resulted accumulation of mutated or misfolded proteins is the essential feature of neurodegenerative disorders. However, in cancers, fibroproliferative diseases or cardiovascular diseases, autophagy can play either a protective or destructive role in different types of disease, and even in different stages of the same disease. The review will discuss the cellular and molecular mechanisms of autophagy and its important role in the pathogenesis of aging and age-related diseases, and the ongoing drug discovery strategies for therapeutic intervention.
Aging
;
Autophagy
;
Drug Discovery
;
Humans
;
Lysosomes
;
metabolism
;
Neurodegenerative Diseases
;
Phagosomes
;
metabolism
;
Protein Folding
5.Mycelium of Hirsutella hepiali Chen et Shen activates autophagy and protects against metabolic syndrome in mice fed with high fat diet.
Xiao-Ming FU ; Jing XIE ; Zhuo-Wei HU
Acta Pharmaceutica Sinica 2014;49(5):615-621
To investigate the protective effects and possible mechanism of Mycelium of Hirsutella hepiali Chen et Shen (MHCS) on metabolic syndromes, free fatty acid and MHCS-treated hepatocytes were used for detecting autophagy-related LC3, p62 and lipid accumulation. Moreover, high fat diet fed mice were used to establish metabolic syndromes model. 50-weeks age mice were randomly divided into: control group, model group and MHCS group. At 80-weeks age, 15 mice were randomly chosen from each group separately for examining oral glucose tolerance, serum insulin, insulin-like growth factor 1 (IGF-1), hepatic LC3, p62, p-NF-kappaB p65, NF-kappaB p65, IL-6 and CXCL-8. Moreover, insulin resistance index (IRI) was calculated. Hepatic pathological changes, including vacuoles, lipids accumulation and fibrosis were observed. Remaining mice were fed with diet separately to 110 weeks-age for statistics of mortality. MHCS promoted autophagy of free fatty acid treated hepatocytes. Mice fed with high fat plus MHCS diet exhibited improved oral glucose tolerance, insulin resistance, hepatic pathology, inflammation, mortality and activated autophagy. The protective effects of MHCS against metabolic syndroms might be through the activation of hepatic autophagy.
Animals
;
Autophagy
;
Diet, High-Fat
;
adverse effects
;
Glucose Tolerance Test
;
Hepatocytes
;
metabolism
;
pathology
;
Hypocreales
;
Insulin
;
blood
;
Insulin Resistance
;
Insulin-Like Growth Factor I
;
metabolism
;
Interleukin-6
;
metabolism
;
Interleukin-8
;
metabolism
;
Liver
;
metabolism
;
pathology
;
Male
;
Metabolic Syndrome
;
etiology
;
metabolism
;
pathology
;
Mice
;
Mice, Inbred C57BL
;
Microtubule-Associated Proteins
;
metabolism
;
Mycelium
;
physiology
;
Random Allocation
;
Transcription Factor RelA
;
metabolism
;
Transcription Factors
;
metabolism
6.Integrating problem-based learning with mobile learning on virtual hospital platform
Hong ZHANG ; Xufang SUN ; Weikun HU ; Hao DU ; Wei WANG ; Zhuo CHEN
Chinese Journal of Medical Education Research 2013;(10):1057-1059,1060
Mobile learning has the characteristics of mobility,timeliness,network and virtu-ality. We developed virtual hospital suitable for mobile devices and organized students in to a network. Through early training,clinical case screen,learning objective fix,learning process and results evaluation,mobile devices were employed to do problem-based learning,which is conducive to the integration of theory with practice,the shifting from discipline-centered to system-based courses and the improving of utilization rate of learning resource.
7.Application of full-field digital mammography three-dimensional positioning system for localization of nonpalpable breast lesions
Pin NIE ; Bei ZHANG ; Lina HU ; Zhuo XIE ; Wei GUO ; Baoying CHEN
Journal of Practical Radiology 2017;33(9):1436-1438
Objective To evaluate the clinical value of full-field digital mammography three-dimensional (3D) positioning system for localization and excision of nonpalpable breast lesions.Methods 106 patients with nonpalpable breast lesions and underwent preoperative localization were analyzed retrospectively.They underwent wire-localization operation guided by mammography 3D positioning system (GE Senogrphe DS).The depth of wire insertion was calculated manually and automatically.Combined with the manual measurement, systematic measurement, skin elasticity and breast parenchyma structure, the positioning wire was placed.Then, the clinical resection was performed according to the wire localization.Results The localization accuracy of mammography 3D positioning system was 100%.11 patients appearedsyncope.With the rest, psychological comfort and fluid infusion, patients recovered quickly.Conclusion Full-field digital mammography 3D positioning system can improve the accuracy of clinical resection of nonpalpable breast lesion.
8.TRIB3 promotes lung cancer cell survival and inhibits apoptosis through NRF2 activation
Jiao-jiao YU ; Cheng ZHANG ; Yu-jin XIANG ; Zhuo-wei HU ; Bing CUI ; Fang HUA
Acta Pharmaceutica Sinica 2021;56(5):1352-1359
The nuclear transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) plays a crucial role in maintaining cellular redox homeostasis. The aberrant NRF2 signaling confers enhanced antioxidant capacity, which is linked to tumor progression and therapeutic resistance. The current study investigates the biological effects and molecular mechanism of tribbles homolog 3 (TRIB3), a stress-induced protein, in regulating cell survival and apoptosis in lung cancer. This study first performed the RNA sequencing data analysis with 576 lung adenocarcinoma patients from the cancer genome atlas (TCGA) database. The NRF2- antioxidant response element (ARE) signature was enriched in patients with high TRIB3 expression. Dual-luciferase reporter assay and real-time quantitative polymerase chain reaction (PCR) were used to confirm the effect of TRIB3 on the kelch-like ECH-associated protein-1 (KEAP1)-NRF2 pathway. Abrogation of
9.Research progress of chemokines and their receptors in breast cancer
Wan-yu WANG ; Xiao-xi LÜ ; Zhuo-wei HU ; Shan-shan LIU
Acta Pharmaceutica Sinica 2021;56(6):1521-1531
Chemokines are small cytokines with chemotactic activity, they are involved in regulating immune responses and inflammatory responses. In the development of tumors, chemokines are multi-functional mediators that not only affect the infiltration of immune cells into the tumor, but also have an important impact on tumor growth, angiogenesis, invasion, and metastasis. Besides, they are important targets of tumor therapy. Here we review chemokines involved in the regulation of signaling pathways, analyze the mechanism of chemokines in the development of breast cancer, summarize the chemokines targeted drugs for breast cancer in recent years and make a prospect about the role of chemokines in anti-breast cancer therapy.
10.Reversion of multidrug resistance (MDR) in human glioma cells by RNA interference (RNAi).
Peng ZHAO ; Wei HU ; Ya-zhuo ZHANG ; Mei-zhen SUN ; Yue HE
Chinese Journal of Oncology 2006;28(3):183-187
OBJECTIVETo explore whether the constructed vector of short haprin in vivo can induce human glioma cell line BT325 to produce RNAi duplexes and reverse the expression of MDR1 gene.
METHODSThree 62nt oligonucleotide fragments (shRNA) were constructed according to GenBank MDR1 sequence and were cloned to the retrovirus-delivered vectors. After transfected these vectors directly into the human malignant glioma BT325 cells by lipofectamine 2000 with enhanced green fluorescence protein (EGFP) co-transfecting, the MDR1 gene silence effects were detected by the changing level of mRNA and P-glycoprotein including real time PCR (RT-PCR), Northern blot and Western blot analysis. To assess the multidrug resistance against adriamycin (ADR) and VCR, cell proliferation assays were performed by cell counting kit-8.
RESULTSThe RNAi plasmid vectors were constructed successfully. RT-PCR showed MDR1 mRNA was significantly reduced (P < 0.05). Northern blot analysis showed that the gene silence became most intense at 48 hours after transfection. Western blot analysis demonstrated that P-gp expression was reduced at different time to 12.9%, 30.3% and 4.8%, respectively. The chemosensitivity assays indicated that the transfected cells showed an enhanced sensitivity to ADR and VCR. Based on the value of IC(50), BT325 cells had significantly increased sensitivity to the drugs.
CONCLUSIONThe sequence specific RNAi can inhibit MDR1 mRNA and P-gp expression in the glioma cell line. It may reverse multidrug resistance phenotype, therefore, may provide promising therapeutic modalities in the treatment of human glioma.
ATP-Binding Cassette, Sub-Family B, Member 1 ; biosynthesis ; genetics ; Antibiotics, Antineoplastic ; pharmacology ; Antineoplastic Agents, Phytogenic ; pharmacology ; Cell Line, Tumor ; Doxorubicin ; pharmacology ; Drug Resistance, Multiple ; drug effects ; Drug Resistance, Neoplasm ; drug effects ; Glioma ; metabolism ; pathology ; Humans ; Plasmids ; RNA Interference ; RNA, Messenger ; biosynthesis ; genetics ; RNA, Small Interfering ; genetics ; pharmacology ; Transfection ; Vincristine ; pharmacology